[1] 肖月, 隋宾艳, 赵琨. 我国终末期肾病现状及透析技术的应用、费用及支付情况分析[J]. 中国卫生政策研究, 2011, 4(5):29-33.
[2] 宋康康, 赵德龙, 陈香美. 维持性血液透析患者死亡相关危险因素综述[J]. 解放军医学院学报, 2017, 38(5): 471-474.
[3] Ott HC, Matthiesen TS, Goh SK, et al. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart[J]. Nat Med, 2008, 14(2):213-221.
[4] 史跃先, 黎磊石, 周虹, 等. IgA肾病肾组织内胶原蛋白Ⅳ的分布及意义[J]. 解放军医学杂志, 1993, 14(2):114-117.
[5] Peloso A, Petrosyan A, Da Sacco S, et al. Renal extracellular matrix scaffolds from discarded kidneys maintain glomerular morphometry and vascular resilience and retains critical growth factors[J]. Transplantation, 2015, 99(9):1807-1816.
[6] Huang J, Wang H, Fan ST, et al. The national program for deceased organ donation in China[J]. Transplantation, 2013, 96(1):5-9.
[7] Madariaga ML, Ott HC. Bioengineering kidneys for transplantation[J]. Semin Nephrol, 2014, 34(4):384-393.
[8] 韩雪峰, 杨大平, 郭铁芳. 曲拉通X-100对制备脱细胞血管基质影响的实验研究[J]. 中华外科杂志, 2002, 40(1):27-29.
[9] 秦雨萌, 周涛, 张璐, 等. 大鼠单叶肝去细胞生物支架的制备与鉴定[J]. 解剖学报, 2017, 48(4):477-481.
[10]赵丽娜, 余雅玲, 林刻智, 等. 在体制备大鼠全肾去细胞支架的程序性分析[J]. 解剖学报. 2014, (2):267-272.
[11]Yu YL, Shao YK, Ding YQ, et al. Decellularized kidney scaffold-mediated renal regeneration[J]. Biomaterials, 2014, 35(25):6822-6828.
[12]Guan Y, Liu S, Sun C, et al. The effective bioengineering method of implantation decellularized renal extracellular matrix scaffolds[J]. Oncotarget, 2015, 6(34):36126-36138.
[13]Du C, Narayanan K, Leong MF, et al. Functional Kidney Bioengineering with Pluripotent Stem-Cell-Derived Renal Progenitor Cells and Decellularized Kidney Scaffolds[J]. Adv Healthc Mater, 2016, 5(16):2080-2091.
[14]Abolbashari M, Agcaoili SM, Lee MK, et al. Repopulation of porcine kidney scaffold using porcine primary renal cells[J]. Acta Biomater, 2016, 29:52-61. |